Theresa Friederike Bauer

Title: Innovations and Contributions of Theresa Friederike Bauer

Introduction

Theresa Friederike Bauer is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of immunology, particularly in the development of plasma-derived immunoglobulin G (IgG) therapies. With a total of eight patents to her name, her work has had a substantial impact on the treatment of viral infections.

Latest Patents

One of her latest patents is titled "Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS." This invention provides methods for the manufacture of plasma-derived immunoglobulin G compositions that are highly enriched for anti-parvo B19 immunoglobulin G. The methods do not affect the existing manufacturing processes or capabilities for producing plasma-derived IgG therapeutics. Additionally, she has developed a method to produce a highly concentrated immunoglobulin preparation for subcutaneous use. This method relates to preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection, resulting in a composition comprising 20% or more immunoglobulin suitable for such use.

Career Highlights

Throughout her career, Theresa has worked with notable companies in the pharmaceutical industry, including Baxalta GmbH and Takeda Pharmaceutical Company Limited. Her expertise in immunoglobulin therapies has positioned her as a key figure in the development of innovative treatments.

Collaborations

Theresa has collaborated with esteemed colleagues such as Wolfgang Teschner and Harald Arno Butterweck. These partnerships have further enhanced her research and development efforts in the field of immunology.

Conclusion

Theresa Friederike Bauer's contributions to immunology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of viral infections.